99mTc-labeled monosaccharide kits: development methods and quality control
| Parent link: | Scientific Reports Vol. 10.— 2020.— [5121, 9 p.] |
|---|---|
| Corporate Author: | Национальный исследовательский Томский политехнический университет Физико-технический институт Лаборатория № 31 ядерного реактора |
| Other Authors: | Stasyuk (Stasiuk) E. S. Elena Sergeyevna, Skuridin V. S. Viktor Sergeyevich, Rogov A. S. Alexander Sergeyevich, Zelchan R. V. Roman Vladimirovich, Sadkin V. L. Vladimir Leonidovich, Varlamova N. V. Natalya Valeryevna, Nesterov E. A. Evgeny Alexandrovich |
| Summary: | Title screen The paper presents the procedure for planning an experiment to create standard sets of reagents for a technetium-99m generator based on glucose derivatives. All stages are presented from researching the required quantities of a substance, a reducing agent, a stabilizer and auxiliary components to developing lyophilized kits and conducting quality control. The radiochemical purity of radiopharmaceuticals prepared on the basis of the developed kits ranged from 90.0 to 99.0%. We also showed the functional suitability of the developed preparations on C57B1/6j mice with an implanted malignant tumor - Lewis lung carcinoma. |
| Published: |
2020
|
| Subjects: | |
| Online Access: | http://earchive.tpu.ru/handle/11683/65323 https://doi.org/10.1038/s41598-020-61707-7 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=662005 |
Similar Items
99mTc-labeled nanocolloid drugs: development methods
Published: (2020)
Published: (2020)
Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer
Published: (2021)
Published: (2021)
Use of multi-angle ultra-wide band microwave sounding for high resolution breast imaging
Published: (2020)
Published: (2020)
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
Published: (2020)
Published: (2020)
Cancer-Targeted Drug Delivery
Published: (2025)
Published: (2025)
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?
Published: (2025)
Published: (2025)
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors
Published: (2024)
Published: (2024)
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8
Published: (2025)
Published: (2025)
Investigation of the Size Distribution for Diffusion-Controlled Drug Release From Drug Delivery Systems of Various Geometries
by: Spiridonova T. I. Tatjyana Igorevna
Published: (2019)
by: Spiridonova T. I. Tatjyana Igorevna
Published: (2019)
Development and Study of {99m}Tc-1-Thio-D-glucose for Visualization of Malignant Tumors
Published: (2017)
Published: (2017)
Study of potential utility of new radiopharmaceuticals based on technetium-99m labeled derivative of glucose
Published: (2016)
Published: (2016)
All-Optical Nanoscale Heating and Thermometry with Resonant Dielectric Nanoparticles for Controllable Drug Release in Living Cells
Published: (2020)
Published: (2020)
Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation
Published: (2025)
Published: (2025)
Chitosan-collagen based film for controlled delivery of a combination of short life anesthetics
Published: (2019)
Published: (2019)
Porous Inorganic Carriers Based on Silica, Calcium Carbonate and Calcium Phosphate for Controlled/Modulated Drug Delivery: Fresh Outlook and Future Perspectives
Published: (2018)
Published: (2018)
A multi-level thresholding method for breast thermograms analysis using Dragonfly algorithm
Published: (2019)
Published: (2019)
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer
Published: (2023)
Published: (2023)
Fabrication of MoO3/TiO2-SiO2 with hollow spherical shape using resin as the template: Effect of decomposition of resins
Published: (2021)
Published: (2021)
The first experience of using {99m}Tc-Al[2]O[3]-based radiopharmaceutical for the detection of sentinel lymph nodes in cervical cancer patients
Published: (2016)
Published: (2016)
Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
Published: (2021)
Published: (2021)
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
Published: (2020)
Published: (2020)
The first experience of using of {99}mTc-Al[2]O[3] for detection of sentinel lymph nodes in breast cancer
Published: (2016)
Published: (2016)
Silver Nanoparticles Targeting the Drug Resistance Problem of Streptococcus dysgalactiae: Susceptibility to Antibiotics and Efflux Effect
Published: (2022)
Published: (2022)
Controlled drug release from electrospun PCL non-woven scaffolds via multi-layering and e-beam treatment
Published: (2021)
Published: (2021)
Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs
Published: (2023)
Published: (2023)
Preclinical Evaluation of a Novel High-Affinity Radioligand [ 99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)
Published: (2023)
Published: (2023)
Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery
Published: (2022)
Published: (2022)
Possibility for Application of {99m}Tc-Methoxyisobutylisonitrile in Assessing the Efficiency of Chemotherapy Cardiotoxicity Prevention
Published: (2015)
Published: (2015)
Adsorption of 99mTc on aluminum oxide
Published: (2011)
Published: (2011)
Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin
Published: (2019)
Published: (2019)
Разработка высокоспецифичного радиохимического соединения на основе меченых 99mТс рекомбинантных адресных молекул для визуализации клеток с гиперэкспрессией Her-2/neu
Published: (2017)
Published: (2017)
Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer
Published: (2020)
Published: (2020)
Study of a Gglucose Derivative Labeled with Technetium-99m as Potential Radiopharmaceutical for Cancer Diagnosis
Published: (2016)
Published: (2016)
Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer
Published: (2024)
Published: (2024)
66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26
Published: (2021)
Published: (2021)
Free-standing microchamber arrays as a biodegradable drug depot system for implant coatings
Published: (2019)
Published: (2019)
In Vitro Evaluation of a Specific Radiochemical Compound Based on 99mTc-labeled DARPinG3 for Radionuclide Imaging of Tumors Overexpressing Her-2/neu
Published: (2017)
Published: (2017)
Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer
Published: (2020)
Published: (2020)
Deep Learning for Cancer Diagnosis
Published: (2021)
Published: (2021)
Smoking-related DNA adducts as potential diagnostic markers of lung cancer: new perspectives
Published: (2015)
Published: (2015)
Similar Items
-
99mTc-labeled nanocolloid drugs: development methods
Published: (2020) -
Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer
Published: (2021) -
Use of multi-angle ultra-wide band microwave sounding for high resolution breast imaging
Published: (2020) -
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
Published: (2020) -
Cancer-Targeted Drug Delivery
Published: (2025)